better accuracy in detecting cnv and sv mutations
The assessment of somatic variants is crucial for cancer diagnostics, companion diagnostics, and target selection in drug development. The Genoox platform scales and enhances the ability to produce actionable insights from the latest scientific literature, clinical trials, and conference proceedings.
the genoox advantage
Rapid analysis for timely diagnosis and treatment
Follows AMP, NCCN & ASCO guidelines
Identifies SNV’s, CNV’s, and SV genomic alteration
sequencing platforms support
Supports all relevant sequencing platforms (WGS, WES, and panels (both disease state & custom)
Allows different analysis mode
Allows different analysis mode: tumor only, paired normal-tumor or tumor-blood/tissue analysis
Variant detection algorithms
Variant detection algorithms rely on low coverage data, enabling quality results with low DNA sample volumes as often seen with FFPE, without loss in accuracy.
Customizable reporting tools
Customizable reporting tools that can be shared with patients and other physicians